Turck, DominiqueBohn, TorstenCastenmiller, JacquelineDe Henauw, StefaanHirsch-Ernst, Karen IldicoMaciuk, AlexandreMangelsdorf, IngeMcArdle, Harry JNaska, AndronikiPelaez, CarmenPentieva, KristinaSiani, AlfonsoThies, FrankTsabouri, SophiaVinceti, MarcoCubadda, FrancescoFrenzel, ThomasHeinonen, MarinaMarchelli, RosangelaNeuhäuser-Berthold, MonikaPoulsen, MortenPrieto Maradona, MiguelSchlatter, Josef Rudolfvan Loveren, HenkColombo, PaoloNoriega Fernández, EstefaníaKnutsen, Helle KatrineEFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)2023-04-172023-04-172022-12-14Turck, D, Bohn, T, Castenmiller, J, De Henauw, S, Hirsch-Ernst, K I, Maciuk, A, Mangelsdorf, I, McArdle, H J, Naska, A, Pelaez, C, Pentieva, K, Siani, A, Thies, F, Tsabouri, S, Vinceti, M, Cubadda, F, Frenzel, T, Heinonen, M, Marchelli, R, Neuhäuser-Berthold, M, Poulsen, M, Prieto Maradona, M, Schlatter, J R, van Loveren, H, Colombo, P, Noriega Fernández, E, Knutsen, H K & EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2022, 'Safety of 2'-fucosyllactose (2'-FL) produced by a derivative strain (APC199) of Corynebacterium glutamicumATCC 13032 as a novel food pursuant to Regulation (EU) 2015/2283.', EFSA Journal, vol. 20, no. 12, e07647. https://doi.org/10.2903/j.efsa.2022.76471831-4732PubMedCentral: PMC9749449ORCID: /0000-0002-9275-9713/work/133393425https://hdl.handle.net/2164/20482Requestor: European Commission Question number: EFSA-Q-2020-00500 Correspondence: nif@efsa.europa.eu212424724engSDG 3 - Good Health and Well-being2′-fucosyllactose2′-FLhuman milk oligosaccharideHMOHiMOnovel foodsafetyR MedicineQH301 BiologyEuropean CommissionSupplementary InformationRQH301Journal article10.2903/j.efsa.2022.76472012